Marc Yoskowitz

Marc Yoskowitz

Director/Board Member at MEREO BIOPHARMA GROUP PLC

Net worth: - $ as of 29/04/2024

49 year
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Marc J.
Yoskowitz
is a Chief Executive Officer at Evozyne Inc and a Chief Strategy Officer & EVP-Life Sciences at Tempus AI, Inc. He is on the Board of Directors at Mereo BioPharma Group Plc and Endo, Inc. Mr. Yoskowitz was previously employed as a Senior VP-Strategy & Corporate Development by Hospira, Inc., an Associate Principal by McKinsey & Co., Inc., a Chief Business Officer by Pfizer Essential Health, and a Chief Strategy Officer & Executive Vice President by Tempus, Inc. He received his undergraduate degree from Washington University in St. Louis and a graduate degree from Columbia Law School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/02/2024 0 ( -.--% ) - $ 29/04/2024

Marc Yoskowitz active positions

CompaniesPositionStart
MEREO BIOPHARMA GROUP PLC Director/Board Member 09/11/2022
Chief Executive Officer 03/01/2023
Corporate Officer/Principal 31/01/2019
All active positions of Marc Yoskowitz

Former positions of Marc Yoskowitz

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
HOSPIRA, INC. Corporate Officer/Principal -
See the detail of Marc Yoskowitz's experience

Training of Marc Yoskowitz

Washington University in St. Louis Undergraduate Degree
Columbia Law School Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marc Yoskowitz's experience

Connections

41

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
MEREO BIOPHARMA GROUP PLC

Health Technology

Private companies6

Health Technology

Commercial Services

Consumer Non-Durables

Technology Services

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Marc Yoskowitz